Zebra Medical Vision receives FDA approval for world’s first AI chest X-ray triage product. Credit: PRNewsfoto/Zebra Medical Vision.

Israeli company Zebra Medical Vision has secured 510(k) clearance from the US Food and Drug Administration (FDA) for an artificial intelligence (AI)-powered chest X-ray triage product.

Named HealthPNX, the product is designed to provide an AI alert for urgent findings of pneumothorax. The company said that the technology showed potential to reduce turnaround time.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Pneumothorax is characterised by accumulation of gas within the space between the lung and the chest wall that can lead to total lung collapse. It is usually diagnosed by chest X-ray scan but is difficult to interpret.

Misdiagnosis or late diagnosis of the condition is known to impact nearly 74,000 people in the US per year.

“Zebra-Med’s acute CXR pneumothorax and CT Brain bleed products demonstrated potential to reduce turnaround time and increase the radiologist’s confidence in making diagnoses.”

HealthPNX analyses CXR or digital radiography (DR) scans to automatically detect findings that indicate pneumothorax and notifies the medical team.

Compared to the standard First In First Out (FIFO) approach, the AI solution is claimed to save more than 80% of the time taken to reach the acute condition.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Chairman of Imaging at Alvert Einstein Medical Center Dr Terence Matalon said: “In a clinical validation study we performed, Zebra-Med’s acute CXR pneumothorax and CT Brain bleed products demonstrated a promising potential to substantially reduce turnaround time and increase the radiologist’s confidence in making these diagnoses.”

Using millions of images, the product was trained to identify more than 40 common clinical findings. Results from the Textray study showed high agreement rates between the algorithm and human radiologist experts.

Zebra Medical Vision CEO and co-founder Eyal Gura said: “We are happy to add this important capability to our All-in-One (AI1) package and add more value to busy radiology departments.

“Health providers across the US that already use the many Zebra-integrated PACS and worklist systems, will be able to easily deploy our triage solution and improve their patients’ care and outcomes.”